Search - Prime Therapeutics
-
BioSpace: As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health outcomes—evidenced by successful studies in therapeutic areas like...
PA Sub-Categories: GLP-1 Prime Article: In the News -
As demand for GLP-1a drugs for weight loss has increased, new data provides additional insights about this new class of medications.
PA Sub-Categories: GLP-1 Prime Article: Press Releases -
Specialty Pharmacy Continuum
PA Sub-Categories: GLP-1 Prime Article: In the News -
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News -
Academy of Managed Care Pharmacy (AMCP)
PA Sub-Categories: GLP-1 Prime Article: In the News -
BioPharma Dive: There are no drugs specifically for polycystic ovary syndrome, a chronic condition that can cause infertility. One study is testing whether Wegovy might be beneficial.
PA Sub-Categories: GLP-1 Prime Article: In the News -
Quarterly Drug Pipeline: January 2024 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-january-2024 About Prime...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
Quarterly Drug Pipeline: April 2024 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-april-2024 About Prime...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
Quarterly Drug Pipeline: July 2024 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-july-2024 About Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
publications Quarterly Drug Pipeline: July 2024 Clinical insights and competitive intelligence on anticipated drugs in development Editor-in-chief's message Welcome to the Prime Quarterly Drug...